Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS103HP in ACL reconstruction
NCT00226759Phase 3Completed
- Sponsor
- Omeros Corporation
- Start
- Nov 2004
- Primary completion
- Sep 2010
- Countries
- 2
01
Overview
A Phase 3 trial of OMS-103HP in anterior cruciate ligament injury, sponsored by Omeros Corporation. Started Nov 2004; status: completed.
02
Drugs
OMS-103HP
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT00226759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226759.